These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 25040613

  • 1. Once-daily fluticasone furoate 50 mcg in mild-to-moderate asthma: a 24-week placebo-controlled randomized trial.
    Busse WW, Bateman ED, O'Byrne PM, Lötvall J, Woodcock A, Medley H, Forth R, Jacques L.
    Allergy; 2014 Nov; 69(11):1522-30. PubMed ID: 25040613
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial.
    O'Byrne PM, Woodcock A, Bleecker ER, Bateman ED, Lötvall J, Forth R, Medley H, Jacques L, Busse WW.
    Respir Res; 2014 Aug 11; 15(1):88. PubMed ID: 25108545
    [Abstract] [Full Text] [Related]

  • 3. Once-daily fluticasone furoate/vilanterol versus twice-daily fluticasone propionate/salmeterol in patients with asthma well controlled on ICS/LABA.
    Bernstein D, Andersen L, Forth R, Jacques L, Yates L.
    J Asthma; 2018 Sep 11; 55(9):984-993. PubMed ID: 28961020
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
    Medley H, Orozco S, Allen A.
    Clin Ther; 2012 Aug 11; 34(8):1683-95. PubMed ID: 22796247
    [Abstract] [Full Text] [Related]

  • 5. Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial.
    Woodcock A, Bateman ED, Busse WW, Lötvall J, Snowise NG, Forth R, Jacques L, Haumann B, Bleecker ER.
    Respir Res; 2011 Oct 06; 12(1):132. PubMed ID: 21977941
    [Abstract] [Full Text] [Related]

  • 6. Fluticasone furoate/vilanterol 200/25 mcg in Asian asthma patients: a randomized trial.
    Lin J, Kang J, Lee SH, Wang C, Zhou X, Crawford J, Jacques L, Stone S.
    Respir Med; 2015 Jan 06; 109(1):44-53. PubMed ID: 25524507
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids.
    Bleecker ER, Bateman ED, Busse WW, Woodcock A, Frith L, House KW, Jacques L, Davis AM, Haumann B, Lötvall J.
    Ann Allergy Asthma Immunol; 2012 Nov 06; 109(5):353-358.e4. PubMed ID: 23062392
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of Once-Daily Vilanterol/Fluticasone furoate MDI in persistent asthma: Phase 3 OD-INHALE Study.
    Kumar A, Jain MK, Barge VB, Kumar RS, Gupta N, Yadav H, Pal A, Redkar VE, Mondal A, Rathore RK, Daultani P, Jaiswal A, Mehta RT.
    J Asthma; 2024 Oct 06; 61(10):1181-1189. PubMed ID: 38488853
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients.
    Dransfield MT, Feldman G, Korenblat P, LaForce CF, Locantore N, Pistolesi M, Watkins ML, Crim C, Martinez FJ.
    Respir Med; 2014 Aug 06; 108(8):1171-9. PubMed ID: 24998880
    [Abstract] [Full Text] [Related]

  • 13. Randomised trial of once-daily vilanterol in children with asthma on inhaled corticosteroid therapy.
    Oliver AJ, Covar RA, Goldfrad CH, Klein RM, Pedersen SE, Sorkness CA, Tomkins SA, Villarán C, Grigg J.
    Respir Res; 2016 Apr 05; 17():37. PubMed ID: 27044326
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety evaluation of once-daily fluticasone furoate/vilanterol in Asian patients with asthma uncontrolled on a low- to mid-strength inhaled corticosteroid or low-dose inhaled corticosteroid/long-acting beta2-agonist.
    Lin J, Tang H, Chen P, Wang H, Kim MK, Crawford J, Jacques L, Stone S.
    Allergy Asthma Proc; 2016 Jul 05; 37(4):302-10. PubMed ID: 27401316
    [Abstract] [Full Text] [Related]

  • 15. Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma.
    Woodcock A, Bleecker ER, Busse WW, Lötvall J, Snowise NG, Frith L, Jacques L, Haumann B, Bateman ED.
    Respir Res; 2011 Dec 21; 12(1):160. PubMed ID: 22188590
    [Abstract] [Full Text] [Related]

  • 16. Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma.
    O'Byrne PM, Bleecker ER, Bateman ED, Busse WW, Woodcock A, Forth R, Toler WT, Jacques L, Lötvall J.
    Eur Respir J; 2014 Mar 21; 43(3):773-82. PubMed ID: 24136330
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: a 24-week placebo and active-controlled randomised trial.
    Lötvall J, Bleecker ER, Busse WW, O'Byrne PM, Woodcock A, Kerwin EM, Stone S, Forth R, Jacques L, Bateman ED.
    Respir Med; 2014 Jan 21; 108(1):41-9. PubMed ID: 24295556
    [Abstract] [Full Text] [Related]

  • 18. Fluticasone furoate (FF)/vilanterol (100/25 mcg or 200/25 mcg) or FF (100 mcg) in persistent asthma.
    Bernstein DI, Bateman ED, Woodcock A, Toler WT, Forth R, Jacques L, Nunn C, O'Byrne PM.
    J Asthma; 2015 Jan 21; 52(10):1073-83. PubMed ID: 26291137
    [Abstract] [Full Text] [Related]

  • 19. A phase IIb, randomised, parallel-group study: the efficacy, safety and tolerability of once-daily umeclidinium in patients with asthma receiving inhaled corticosteroids.
    Kerwin E, Pascoe S, Bailes Z, Nathan R, Bernstein D, Dahl R, von Maltzahn R, Robbins K, Fowler A, Lee L.
    Respir Res; 2020 Jun 12; 21(1):148. PubMed ID: 32532275
    [Abstract] [Full Text] [Related]

  • 20. Fluticasone furoate demonstrates efficacy in patients with asthma symptomatic on medium doses of inhaled corticosteroid therapy: an 8-week, randomised, placebo-controlled trial.
    Busse WW, Bleecker ER, Bateman ED, Lötvall J, Forth R, Davis AM, Jacques L, Haumann B, Woodcock A.
    Thorax; 2012 Jan 12; 67(1):35-41. PubMed ID: 21828231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.